Innophos Holdings (Innophos Holdings) Days Sales Outstanding : 49.44 (As of Sep. 2019)

View and export this data going back to 2006. Start your Free Trial

What is Innophos Holdings Days Sales Outstanding?

Innophos Holdings's average Accounts Receivable for the three months ended in Sep. 2019 was $102.6 Mil. Innophos Holdings's Revenue for the three months ended in Sep. 2019 was $189.3 Mil. Hence, Innophos Holdings's Days Sales Outstanding for the three months ended in Sep. 2019 was 49.44.

The historical rank and industry rank for Innophos Holdings's Days Sales Outstanding or its related term are showing as below:

IPHS's Days Sales Outstanding is not ranked ^*
in the Chemicals industry.
Industry Median: 63.74
* Ranked among companies with meaningful Days Sales Outstanding only.

Innophos Holdings's Days Sales Outstanding increased from Sep. 2018 (49.12) to Sep. 2019 (49.44).

Innophos Holdings Days Sales Outstanding Historical Data

The historical data trend for Innophos Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innophos Holdings Days Sales Outstanding Chart

Innophos Holdings Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Days Sales Outstanding

Get a 7-Day Free Trial

38.92

39.38

39.61

45.12

46.29

Innophos Holdings Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Days Sales Outstanding	Get a 7-Day Free Trial															49.12	48.68	51.08	51.95	49.44

Competitive Comparison of Innophos Holdings's Days Sales Outstanding

For the Specialty Chemicals subindustry, Innophos Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innophos Holdings's Days Sales Outstanding Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innophos Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Innophos Holdings's Days Sales Outstanding falls into.

Innophos Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Innophos Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2018 is calculated as

	Days Sales Outstanding (A: Dec. 2018 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2017 )	+	Accounts Receivable (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )	*	Days in Period
=	( (100.82	+	102.564)	/	2 )	/	801.842	*	365
=	101.692					/	801.842	*	365
=	46.29

Innophos Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2019 is calculated as:

	Days Sales Outstanding (Q: Sep. 2019 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2019 )	+	Accounts Receivable (A: Sep. 2019 ))	/	count )	/	Revenue (A: Sep. 2019 )	*	Days in Period
=	( (98.957	+	106.219)	/	2 )	/	189.349	*	365 / 4
=	102.588					/	189.349	*	365 / 4
=	49.44

Innophos Holdings (NAS:IPHS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Innophos Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Innophos Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Innophos Holdings (Innophos Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innophos Holdings Inc (NAS:IPHS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

259 Prospect Plains Road, Cranbury, NJ, USA, 08512

Website

http://www.innophos.com

Innophos Holdings Inc is a holding company that manufactures and sells through its subsidiaries a variety of ingredients used in the production of food, beverages, dietary supplements, pharmaceuticals, and oral care products. Innophos ingredients are made primarily from specialty phosphates. The company organizes itself into three segments namely Food, Health and Nutrition; Industrial Specialties and Other. The Food, Health and Nutrition segment contribute the maximum revenue. The company operates in U.S., Canada, Mexico and other countries.

Executives

John M Steitz	director	ALBEMARLE CORP, 451 FLORIDA ST, BATON ROUGE LA 70801
Kim Ann Mink	director, officer: Chairman, CEO, President	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Gary A Cappeline	director	50 E RIVERCENTER BLVD, COVINGTON KY 41012
Karen R Osar	director	C/O WESTVACO CORP, ONE HIGH RIDGE PARK, STAMFORD CT 06905
Mark Santangelo	officer: Sr. VP, Mfg, Eng & EH&S	15710 JOHN F. KENNEDY BLVD., SUITE 300 HOUSTON TX 77032
Peter T Thomas	director	1000 LAKESIDE AVENUE, CLEVELAND OH 44114
Hermanus Kieftenbeld	officer: Senior VP and CFO	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
James P. Zallie	director	5 WESTBROOK CORPORATE CENTER, WESTCHESTER IL 60154
Randy Gress	director, officer: CEO	259 PROSPECT PLAINS ROAD, P O BOX 8000, CRANBURY NJ 08512-8000
Stephen M Zide	director	BAIN CAPITAL PARTNERS, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Richard Heyse	officer: VP-Chief Financial Officer	259 PROSPECT PLAINS ROAD, BUILDING G, P O BOX 8000, CRANBURY NJ 08512-8000
Bain Capital Investors Llc	10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Vii Lp	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Llc	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Lp	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116